Taken together, these findings support the conclusion that inhibition of AHN at least partially lead to cognitive impairment caused by sevoflurane, which is probably attributed to the downregulation of BDNF/TrkB and NT-3/TrkC pathways. The gene discussed is NTF3; the disease is Cognitive impairment.